295 results on '"Cliffton, E"'
Search Results
102. HEPATIC AND PULMONARY METASTASES FROM A RESECTABLE EXPERIMENTAL CECAL CARCINOMA: THE EFFECT OF HEPATIC PERFUSION WITH NITROGEN MUSTARD COMBINED WITH SYSTEMIC HEPARIN AND FIBRINOLYSIN.
103. Factors affecting the development of metastatic cancer. Effect of alterations in clottin mechanism.
104. The recognition of mediastinal tumors.
105. Technique for visualization and perfusion of bronchial arteries: suggested clinical and diagnostic applications.
106. EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.
107. Mechanism of formation of vascular thrombosis and its treatment with fibrinolysin.
108. Salvage of heart muscle by fibrinolytic therapy after experimental coronary occlusion.
109. [Correction of hemorrhages in splenectomized animals, treated with coumadine; enhancement of the coagulating effect of ellagic acid with vitamin K].
110. The effects of ellagic acid on the coagulation mechanisms and on traumatic bleeding.
111. Blood plasminogen (profibrinolysin) levels in patients with leukemia and lymphoma.
112. The effect of fibrinolytic agents on myocardial infarction.
113. Studies on fibrinolytic activity with venous occlusion: treatment of thrombophlebitis.
114. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
115. Tension on the suture line in peripheral nerve surgery.
116. Physiological mechanisms of fibrinolysis.
117. Fibrinolysin therapy in thromboembolic diseases.
118. Ligation of the vena cava in extending thrombophlebitis.
119. Changes in the nucleic acid metabolism of the spleen of tumor-bearing rats.
120. Fibrinolytic (plasmin) therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction.
121. Organ localization and the effect of trauma on the fate of circulating cancer cells.
122. Treatment of pulmonary embolism with fibrinolytic agents.
123. Evaluation of a cancer detection clinic.
124. An evaluation of fibrinolysin therapy in acute myocardial infarction.
125. Carcinoma of the pancreas.
126. The use of plasmin in the treatment of intravascular thromboses.
127. Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat.
128. The effect of fibrinolysin and heparin on the formation of peritoneal adhesions.
129. Experimental reconstruction of the trachea with bladder mucosa.
130. The lysis of intravascular thrombi in rabbits with human plasmin (fibrinolysin).
131. The silicone clotting time modified by electric current, as a test to predict a tendency to surgical bleeding.
132. Proteolytic and fibrinolytic activity of serum; activation by streptokinase and staphylokinase indicating dissimilarity of enzymes.
133. FIBRINOLYSIN AND ITS RELATION TO THE MANAGEMENT OF CORONARY THROMBOSIS.
134. The megakaryocyte blood count.
135. The effect of human fibrinolysin on pulmonary metastases of Walker 256 carcinosarcoma.
136. Induction of fibrinolysis by hyperventilation with oxygen and carbon dioxide.
137. Pancreatic deoxyribonuclease (dornase) aerosol in treatment of bronchopulmonary complications and tracheitis sicca.
138. The effect of fibrinogen concentration on susceptibility of clots to in vitro clot lysis with plasmin.
139. Decrease in pulmonary metastases: potentiation of nitrogen mustard effect by heparin and fibrinolysin.
140. Studies of intravascular clot lysis with human fibrinolysin.
141. Fibrinolytic therapy for thrombo-embolic disease: principles and practice.
142. Carcinoma of the pancreas; symptoms, signs, and results of treatment in one hundred twenty-two cases.
143. Pancreatic dornase aerosol in pulmonary, endotracheal and endobronchial disease.
144. Effect of fibrinolysin on spread of cancer.
145. Control of bleeding in splenectomized and coumadin treated animals: potentiation of ellagic acid effect with vitamin K.
146. Effect of cyclopropane anesthesia on blood coagulation.
147. Fibrinolysis and proteolysis in patients with lymphoma.
148. The present status of therapeutic use of enzymes.
149. [Hypercoagulability induced through intravenous injection of a suspension of ellagic acid].
150. Lysis of intravascular blood clots. Fibrinolysin therapy. Indications, contraindications, and results.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.